Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry.

When percutaneous coronary intervention (PCI) is performed in patients with multivessel coronary disease, a targeted revascularization (TR) of diseased vessels is performed more often than complete revascularization (CR). We compared baseline characteristics and 1-year outcomes of patients undergoing TR by operator choice (n = 1,091), TR because CR was unachievable (n = 375), and CR (n = 315) in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Patients receiving TR because CR was unachievable were older, had more comorbidities, worse ejection fraction, less often received 2b/3a inhibitors and stents, and less frequently achieved complete angiographic success than either patients receiving TR by choice or CR. Despite these considerable differences, cumulative rates of 1-year mortality, the need for repeat PCI, or coronary bypass surgery were similar in patients who received CR, TR by choice, or TR because CR was unachievable. In multivariable models, after adjustment for clinical characteristics and propensity to receive CR, the hazard ratio for CR versus TR was 1.10 (95% CI: 0.58-2.10) for 1-year mortality; 0.89 (0.60-1.32) for repeat PCI, and 0.92 (0.66-1.29) for repeat PCI or coronary bypass surgery. In conclusion, despite the presence of more unfavorable characteristics, patients undergoing TR demonstrate 1-year outcomes equivalent to those having CR, supporting its continued use in selected patients.

[1]  M. Hlatky,et al.  Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients , 2006, Circulation.

[2]  P. Serruys,et al.  Complete Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention , 2006, Circulation.

[3]  A. Jacobs,et al.  Recent trends in the percutaneous treatment of chronic total coronary occlusions. , 2006, The American journal of cardiology.

[4]  Samin K. Sharma,et al.  Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.

[5]  W. Laskey,et al.  Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention , 2005, Circulation.

[6]  Antonio Colombo,et al.  Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. , 2005, Circulation.

[7]  P. Serruys,et al.  Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. , 2004, American heart journal.

[8]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[9]  Maria Mori Brooks,et al.  Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease: A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study , 2002, Circulation.

[10]  H. Schaff,et al.  What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). , 2002, Journal of the American College of Cardiology.

[11]  P. Serruys,et al.  The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. , 2002, Journal of the American College of Cardiology.

[12]  Jerome Sacks,et al.  Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. , 2002, Journal of the American College of Cardiology.

[13]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[14]  I. Palacios,et al.  Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. , 2001, Journal of the American College of Cardiology.

[15]  R. Frye,et al.  Long-Term Clinical Outcome in the Bypass Angioplasty Revascularization Investigation Registry Comparison With the Randomized Trial , 2000 .

[16]  A. Jacobs,et al.  Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.

[17]  K. Detre,et al.  Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry. , 1998, European heart journal.

[18]  I. Palacios,et al.  Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. , 1993, Journal of the American College of Cardiology.

[19]  K. Detre,et al.  Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry). , 1992, The American journal of cardiology.